2 min read
Unlock the Secrets of Effective SD File Preparation for FDA Submissions
In today's world where digital transformation is reshaping industries, even the pharmaceutical sector is not immune to...
Comparability studies are a significant issue for those working in biotherapeutics development, as undetected product changes are considered high risk.
Listen to the full episode on Veristat’s Advancing Revolutionary Therapies Podcast to get important insights and recommendations on how to successfully plan your clinical and CMC manufacturing development plans to reduce your regulatory risk along the way.
Learning Points
Meet Veristat. Learn More.
2 min read
Sep 20, 2023 Veristat Blog
In today's world where digital transformation is reshaping industries, even the pharmaceutical sector is not immune to...
10 min read
Sep 13, 2023 Veristat Blog
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US...